CRBP — CORBUS PHARMACEUTICALS HLDGS

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in CORBUS PHARMACEUTICALS HLDGS (CRBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.22% (2024 Q2)
Avg. % of fund
1.47%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 57,644 +32,243 +126.9% 0.72% $729K $12.65
2024 Q3 REDUCED 25,401 -31,067 -55.0% 0.46% $524K $20.63
2024 Q2 INITIATED 56,468 — — 3.22% $2.6M —
% of Fund (quarterly)    CRBP price (monthly, adj. close)

Other funds also holding CRBP

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 2.32% Prosight Management, LP 3Y 7Y 1.15% Octagon Capital Advisors LP 3Y 0.94% Cormorant Asset Management, LP 3Y 7Y 0.88% Exome Asset Management LLC 0.54% Seven Fleet Capital Management LP 0.35% SHERBROOKE PARK ADVISERS LLC 3Y 0.32% Atle Fund Management AB 3Y 7Y 0.28% ORBIMED ADVISORS LLC 3Y 7Y 0.27% ADAR1 Capital Management, LLC 0.17%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings